Maria Pinkerneil
Duesseldorf, NW 40225, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Effects of novel HDAC inhibitors on urothelial carcinoma cells.
Journal: Clinical epigenetics
Published: November 29, 2017
Epigenetic Treatment Options in Urothelial Carcinoma.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: September 11, 2017
Differential Effects of Histone Acetyltransferase GCN5 or PCAF Knockdown on Urothelial Carcinoma Cells.
Journal: International journal of molecular sciences
Published: May 23, 2017
The New Immortalized Uroepithelial Cell Line HBLAK Contains Defined Genetic Aberrations Typical of Early Stage Urothelial Tumors.
Journal: Bladder cancer (Amsterdam, Netherlands)
Published: December 31, 2016
HDACs and HDAC Inhibitors in Urothelial Carcinoma - Perspectives for an Antineoplastic Treatment.
Journal: Current medicinal chemistry
Published: September 07, 2016
Checkpoint kinase inhibitor AZD7762 strongly sensitises urothelial carcinoma cells to gemcitabine.
Journal: Journal of experimental & clinical cancer research : CR
Published: August 25, 2016
Evaluation of the Therapeutic Potential of the Novel Isotype Specific HDAC Inhibitor 4SC-202 in Urothelial Carcinoma Cell Lines.
Journal: Targeted oncology
Published: June 03, 2016
Inhibition of Class I Histone Deacetylases 1 and 2 Promotes Urothelial Carcinoma Cell Death by Various Mechanisms.
Journal: Molecular cancer therapeutics
Published: July 23, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026